COBRE: UND: TNF-ALPHA/GLUTAMATE INDUCED CELL DEATH IN ALZHEIMER'S DISEASE
COBRE:UND:TNF-α/谷氨酸诱导的阿尔茨海默病细胞死亡
基本信息
- 批准号:7610475
- 负责人:
- 金额:$ 18.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-07 至 2008-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgonistAlzheimer&aposs DiseaseAmyloid beta-ProteinApoptoticBrain DiseasesCell DeathCellsCessation of lifeComputer Retrieval of Information on Scientific Projects DatabaseConditionDiseaseEnvironmentFundingGlutamate ReceptorGlutamatesGrantIn VitroInflammationInflammatoryInstitutionMediatingMicrogliaMolecular TargetMultiple SclerosisMusN-Methyl-D-Aspartate ReceptorsN-MethylaspartateNatureNecrosisNerve DegenerationNeuronsNeurotransmittersPeroxonitriteProductionRangeReceptor SignalingResearchResearch PersonnelResourcesSenile PlaquesSignal PathwaySignal TransductionSourceTestingToxinTumor Necrosis Factor-alphaUnited States National Institutes of Healthcytokinehuman NOS2A proteinhuman TNF proteinneurotoxicneurotoxicitypreventresponsetumor necrosis factor receptor 1A
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Microglial-dependent inflammation is critical for neurodegenerative conditions ranging from Alzheimer¿s disease (AD) to multiple sclerosis and Parkinson¿s disease. Therefore,toxic microglial proinflammatory products as well as their specific mechanisms of neuronal toxicity are likely common to numerous pathological situations. Identifying the nature of these toxins as well as their modes of action will provide molecular targets for preventing the inflammatory changes in numerous neurodegenerative conditions. Although abundant reactive microglia are found associated with beta-amyloid plaques in AD brains, their precise contribution to cell loss remains speculative. In vitro, fibrils stimulate microglia to secrete neurotoxic products suggesting that microglial inflammation directly contributes to cell death in AD. Preliminary evidence demonstrates that amyloid beta fibrils stimulate cultured mouse microglia to secrete the excitatory neurotransmitter, glutamate, and the pro-inflammatory cytokine, TNF alpha. These proinflammatory secretions directly induce death of mouse cortical neuron cultures in an oxidative damage-dependent fashion requiring increased neuronal expression of inducible nitric oxide synthase and subsequent peroxynitrite production. Neuron death results from coincident stimulation of the TNF receptor (p55) and NMDA receptors, as neither factor, alone, is sufficient to initiate cell death. Accordingly, we will test the hypothesis that AD brains provide the appropriate microglial-mediated inflammatory environment for TNF alpha and glutamate to synergistically stimulate TNF alpha and glutamate receptor signaling pathways and cause cell death. The following specific aims will address this hypothesis:
1) Determine whether necrotic or apoptotic cell death is induced by synergistic stimulation of neuronal cortical cultures with TNF alpha and the glutamate receptor agonist, NMDA.
2) Identify the mechanisms of nontoxic TNF alpha alone and nontoxic NMDA alone-mediated signaling responses in neurons.
3) Determine the mechanisms of the synergistic TNF alpha + NMDA mediated signaling cross-talk responsible for oxidative damage-dependent neuron death.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
小胶质细胞依赖性炎症对于从阿尔茨海默病(AD)到多发性硬化症和帕金森病的神经退行性疾病至关重要。因此,有毒的小胶质细胞促炎产物以及它们的神经元毒性的特定机制可能在许多病理情况下是共同的。确定这些毒素的性质以及它们的作用模式将为预防许多神经退行性疾病中的炎症变化提供分子靶点。虽然在AD脑中发现了与β-淀粉样蛋白斑块相关的丰富的反应性小胶质细胞,但它们对细胞损失的确切贡献仍然是推测性的。在体外,原纤维刺激小胶质细胞分泌神经毒性产物,表明小胶质细胞炎症直接导致AD中的细胞死亡。初步证据表明,淀粉样蛋白β原纤维刺激培养的小鼠小胶质细胞分泌兴奋性神经递质谷氨酸和促炎细胞因子TNF α。这些促炎分泌物直接诱导小鼠皮层神经元培养物的死亡,在一个氧化损伤依赖的方式,需要增加诱导型一氧化氮合酶和随后的过氧亚硝酸盐生产的神经元表达。TNF受体(p55)和NMDA受体的同时刺激导致神经元死亡,因为单独的两种因子都不足以引发细胞死亡。因此,我们将测试AD脑为TNF α和谷氨酸提供适当的小胶质细胞介导的炎症环境以协同刺激TNF α和谷氨酸受体信号传导途径并导致细胞死亡的假设。以下具体目标将解决这一假设:
1)确定TNF α和谷氨酸受体激动剂NMDA协同刺激神经元皮层培养物是否诱导坏死或凋亡性细胞死亡。
2)确定神经元中无毒TNF α单独和无毒NMDA单独介导的信号应答的机制。
3)确定协同TNF α + NMDA介导的信号传导串扰导致氧化损伤依赖性神经元死亡的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Colin K Combs其他文献
Adhesion of monocytes to type I collagen stimulates an APP-dependent proinflammatory signaling response and release of Aβ1-40
- DOI:
10.1186/1742-2094-7-22 - 发表时间:
2010-01-01 - 期刊:
- 影响因子:10.100
- 作者:
Cindy M Sondag;Colin K Combs - 通讯作者:
Colin K Combs
Colin K Combs的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Colin K Combs', 18)}}的其他基金
Communicating Lung Dysfunction to the Brain in Alzheimer's Disease
阿尔茨海默氏病将肺功能障碍传达给大脑
- 批准号:
10711004 - 财政年份:2023
- 资助金额:
$ 18.67万 - 项目类别:
Impact of sex differences on molecular determinants of AD risk and responsiveness to treatment
性别差异对 AD 风险分子决定因素和治疗反应的影响
- 批准号:
10482427 - 财政年份:2021
- 资助金额:
$ 18.67万 - 项目类别:
Oral Cavity and Brain Cross-talk in Alzheimer's Disease
阿尔茨海默病中的口腔和大脑交互作用
- 批准号:
10231824 - 财政年份:2021
- 资助金额:
$ 18.67万 - 项目类别:
Impact of sex differences on molecular determinants of AD risk and responsiveness to treatment
性别差异对 AD 风险分子决定因素和治疗反应的影响
- 批准号:
10295254 - 财政年份:2021
- 资助金额:
$ 18.67万 - 项目类别:
Impact of sex differences on molecular determinants of AD risk and responsiveness to treatment
性别差异对 AD 风险分子决定因素和治疗反应的影响
- 批准号:
10652594 - 财政年份:2021
- 资助金额:
$ 18.67万 - 项目类别:
Communicating Intestinal Inflammation to the Brain in Alzheimer's Disease
阿尔茨海默氏病中肠道炎症与大脑的沟通
- 批准号:
10472821 - 财政年份:2020
- 资助金额:
$ 18.67万 - 项目类别:
Long noncoding RNAs interact with miRNAs to regulate inflammatory response
长非编码 RNA 与 miRNA 相互作用调节炎症反应
- 批准号:
10216960 - 财政年份:2018
- 资助金额:
$ 18.67万 - 项目类别:
Mechanisms of exposure-induced tissue functional and pathological changes in a mouse model of Alzheimer's Disease
阿尔茨海默病小鼠模型暴露引起的组织功能和病理变化的机制
- 批准号:
9908035 - 财政年份:2017
- 资助金额:
$ 18.67万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 18.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 18.67万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 18.67万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 18.67万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 18.67万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 18.67万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 18.67万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 18.67万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 18.67万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 18.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)